810337C
18:1 Cy7 PE
Manufacturer: Sigma Aldrich
CAS Number: 2260669-65-4
Synonym(S): 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(Cyanine 7)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810337C-1-MG | In Stock | ₹ 54,127.58 |
| 5 MG | 810337C-5-MG | In Stock | ₹ 1,46,594.03 |
810337C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 54,127.58
GST (18%): ₹ 9,742.964
Total Price: ₹ 63,870.544
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810337C-1mg)pkg of 5 × 1 mL (810337C-5mg)
manufacturer/tradename
Avanti Polar Lipids 810337C
concentration
1 mg/mL (810337C-1mg)1 mg/mL (810337C-5mg)
shipped in
dry ice
storage temp.
−20°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 2260669-65-4 | 18:1 Cy7 PE | A2B Chem | -- |
Related Products
Description
- General description: 18:1 Cy7 PE or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(Cyanine 7) is a phosphoethanolamine (PE) derivative wherein the amine and hydroxyl groups of PE are substituted with cyanine 7 and dioleoyl-sn-glycerol.
- Application: 18:1 Cy7 PE or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(Cyanine 7) has been used in Forster resonance energy transfer (FRET) dye pairs for small unilamellar vesicles (SUVs) preparation to serve as a model cellular system and to study membrane tension through subjection to osmotic pressure.[1]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810337C-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810337C-1mg)pkg of 5 × 1 mL (810337C-5mg)
manufacturer/tradename: Avanti Polar Lipids 810337C
concentration: 1 mg/mL (810337C-1mg)1 mg/mL (810337C-5mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810337C-1mg)pkg of 5 × 1 mL (810337C-5mg)
manufacturer/tradename:
Avanti Polar Lipids 810337C
concentration:
1 mg/mL (810337C-1mg)1 mg/mL (810337C-5mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 100 μg (with stopper and crimp cap (810340P-100ug))
manufacturer/tradename: Avanti Polar Lipids 810340P
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 100 μg (with stopper and crimp cap (810340P-100ug))
manufacturer/tradename:
Avanti Polar Lipids 810340P
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810345C-1mg)pkg of 5 × 1 mL (810345C-5mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: 1 mg/mL (810345C-1mg)1 mg/mL (810345C-5mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810345C-1mg)pkg of 5 × 1 mL (810345C-5mg)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
1 mg/mL (810345C-1mg)1 mg/mL (810345C-5mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: ≥99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810350P-1MG)
manufacturer/tradename: Avanti Polar Lipids
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
≥99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810350P-1MG)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C